The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
5 01 ACQUISITION CORP | COM | 33836P105 | 2,034 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AC IMMUNE SA | SHS | H00263105 | 12,461 | 2,410,240 | SH | SOLE | 2,410,240 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 9,768 | 1,509,812 | SH | SOLE | 1,509,812 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 39,184 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
ALLOVIR INC | COM | 019818103 | 17,183 | 447,012 | SH | SOLE | 447,012 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 9,340 | 741,290 | SH | SOLE | 741,290 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 69,301 | 3,223,324 | SH | SOLE | 3,223,324 | 0 | 0 | ||
APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 35,386 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 57,005 | 2,195,892 | SH | SOLE | 2,195,892 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 108 | 17,800 | SH | Call | SOLE | 17,800 | 0 | 0 | |
ATRECA INC | CL A COM | 04965G109 | 39,191 | 2,426,685 | SH | SOLE | 2,426,685 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 53,693 | 2,103,950 | SH | SOLE | 2,103,950 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM | G0904B105 | 2,228 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 9,152 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 1,701 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 48,972 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
BIOGEN INC | COM | 09062X103 | 13,247 | 54,100 | SH | Call | SOLE | 54,100 | 0 | 0 | |
C4 THERAPEUTICS INC | COM | 12529R107 | 6,626 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 6,632 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 19,825 | 1,250,001 | SH | SOLE | 1,250,001 | 0 | 0 | ||
CODIAK BIOSCIENCES INC | COM | 192010106 | 3,721 | 115,195 | SH | SOLE | 115,195 | 0 | 0 | ||
CONSONANCE HFW ACQUISITION C | UNIT | G2445M129 | 2,094 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CYCLERION THERAPEUTICS INC | COM | 23255M105 | 4,915 | 1,606,276 | SH | SOLE | 1,606,276 | 0 | 0 | ||
DEERFIELD HEALTHCARE TECH AC | COM | 244413100 | 7,513 | 481,600 | SH | SOLE | 481,600 | 0 | 0 | ||
DEERFIELD HEALTHCARE TECH AC | *W EXP | 244413118 | 1,560 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 4,515 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | UNIT | G3141W114 | 2,132 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | UNIT | G3710A121 | 2,076 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 4,619 | 46,666 | SH | SOLE | 46,666 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 30,114 | 18,939,925 | SH | SOLE | 18,939,925 | 0 | 0 | ||
GOSSAMER BIO INC | NOTE | 38341PAA0 | 27,175 | 30,000,000 | PRN | SOLE | 30,000,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 2,845 | 294,221 | SH | SOLE | 294,221 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 13,480 | 3,421,287 | SH | SOLE | 3,421,287 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 ORD | SHS | G4411D109 | 5,124 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM | G4444C102 | 2,274 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 625 | 25,300 | SH | Call | SOLE | 25,300 | 0 | 0 | |
ITEOS THERAPEUTICS INC | COM | 46565G104 | 8,793 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM | 47760M102 | 5,150 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 995 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 11,570 | 387,357 | SH | SOLE | 387,357 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 57,907 | 1,773,037 | SH | SOLE | 1,773,037 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 6,200 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 2,134 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
LOGICBIO THERAPEUTICS INC | COM | 54142F102 | 5,913 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 1,436 | 94,819 | SH | SOLE | 94,819 | 0 | 0 | ||
METACRINE INC | COM | 59101E103 | 2,620 | 333,332 | SH | SOLE | 333,332 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 101,978 | 464,298 | SH | SOLE | 464,298 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 95,278 | 2,839,884 | SH | SOLE | 2,839,884 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 44,030 | 3,122,704 | SH | SOLE | 3,122,704 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 4,349 | 143,567 | SH | SOLE | 143,567 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 50,767 | 1,544,019 | SH | SOLE | 1,544,019 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 104,672 | 3,092,218 | SH | SOLE | 3,092,218 | 0 | 0 | ||
PANACEA ACQUISITION CORP | UNIT 99/99/9999 | 698102209 | 4,977 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 3,076 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 113,214 | 9,426,640 | SH | SOLE | 9,426,640 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 133,019 | 3,200,649 | SH | SOLE | 3,200,649 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 1,715 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 128,764 | 2,456,854 | SH | SOLE | 2,456,854 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 117,409 | 2,533,635 | SH | SOLE | 2,533,635 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 60,471 | 7,977,702 | SH | SOLE | 7,977,702 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 449 | 48,558 | SH | SOLE | 48,558 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 2,028 | 93,416 | SH | SOLE | 93,416 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 10,850 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | UNIT | G9127T116 | 1,027 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
VINCERA PHARMA INC | COM | 92731L106 | 10,047 | 480,505 | SH | SOLE | 480,505 | 0 | 0 | ||
VINCERA PHARMA INC | *W EXP | 92731L114 | 3,137 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 198,389 | 4,547,072 | SH | SOLE | 4,547,072 | 0 | 0 |